Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer

David P. Steensma, Roy Molina, Jeff A. Sloan, Daniel A. Nikcevich, Paul L. Schaefer, Kendrith M. Rowland, Todor Dentchev, Paul J. Novotny, Loren K. Tschetter, Steven R. Alberts, Thomas F. Hogan, Amy Law, Charles L. Loprinzi

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences